Selected article for: "clinical sample and stool sample"
Author: Liu, Fang; Cai, Zhao-bin; Huang, Jin-song; Yu, Wen-yan; Niu, Hai-ying; Zhang, Yan; Sui, Dong-ming; Wang, Fei; Xue, Li-zhi; Xu, Ai-fang
Title: Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up
  • Cord-id: pen037ms
  • Document date: 2020_6_27
    • ID: pen037ms
    Snippet: The evidence of long-term clinical dynamic on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case are less. We performed a 108 days follow-up on dynamic clinical presentations in a case, who hospitalized three times due to the positive recurrence of SARS-CoV-2 RNA after discharge, to understand the prognosis of the 2019-Coronavirus disease (COVID-19). In this case, positive SARS-CoV-2 recurred even after apparent recovery (normal CT imaging, no clinical symptoms, ne
    Document: The evidence of long-term clinical dynamic on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case are less. We performed a 108 days follow-up on dynamic clinical presentations in a case, who hospitalized three times due to the positive recurrence of SARS-CoV-2 RNA after discharge, to understand the prognosis of the 2019-Coronavirus disease (COVID-19). In this case, positive SARS-CoV-2 recurred even after apparent recovery (normal CT imaging, no clinical symptoms, negative SARS-CoV-2 on stool sample and negative serum IgM test) from COVID-19, viral shedding duration lasted for 65 days, the time from symptom onset to disappearance was up to 95 days. Erythrocyte-associated indicators, liver function and serum lipid metabolism presented abnormal throughout during the observation period. Awareness of atypical presentations such as this one is important to prompt the improvement of the management of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • liver cell and lung liver tissue: 1, 2, 3
    • liver cell and lymphocyte count: 1, 2, 3, 4, 5, 6
    • liver condition and lung liver: 1
    • liver damage and low lymphocyte count: 1
    • liver damage and lung liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • liver damage and lung liver tissue: 1, 2, 3, 4, 5
    • liver damage and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
    • liver dysfunction and low lymphocyte count: 1
    • liver dysfunction and lpv lopinavir: 1
    • liver dysfunction and lung liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver dysfunction and lung liver tissue: 1, 2
    • liver dysfunction and lymphocyte count: 1, 2, 3
    • liver impairment and lung liver: 1, 2
    • liver impairment and lung liver tissue: 1
    • liver impairment and lymphocyte count: 1
    • low lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • low lymphocyte count high crp level and lymphocyte count: 1
    • lpv lopinavir and lymphocyte count: 1
    • lung liver and lymphocyte count: 1, 2, 3